TY - JOUR T1 - The Impact of Control and Mitigation Strategies during the Second Wave of COVID-19 Infections in Spain and Italy JF - medRxiv DO - 10.1101/2021.05.11.21256876 SP - 2021.05.11.21256876 AU - Marco De Nadai AU - Kristof Roomp AU - Bruno Lepri AU - Nuria Oliver Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/11/2021.05.11.21256876.abstract N2 - European countries struggled to fight against the second and the third waves of the COVID-19 pandemic, as the Test-Trace-Isolate (TTI) strategy widely adopted over the summer and early fall failed to effectively contain the spread of the disease. In this paper, we shed light on the effectiveness of such a strategy in two European countries (Spain and Italy) by analysing data from June to December 2020, collected via a large-scale online citizen survey with 95,251 answers in Spain and 43,393 answers in Italy. Through our analysis, we identify several weaknesses in each of the three pillars of the TTI strategy: testing, tracing and isolating. Moreover, we analyse the respondents’ self-reported behaviour before and after the mitigation strategies were deployed during the second wave of infections. We find that the changes in the participants’ behaviour were more pronounced in Italy than in Spain, whereas in both countries, respondents reported being very compliant with individual protection measures, such as wearing facial masks or frequently disinfecting their hands. Finally, we analyse the participants’ perceptions about their government’s measures and the safety of everyday activities and places regarding the risk of getting an infection. We find that the perceived risk is often gender- and age-dependent and not aligned with the risk level identified by the literature. This finding emphasises the importance of deploying public-health communication campaigns to debunk misconceptions about SARS-CoV-2. Overall, our work shows the value of online citizen surveys to quickly and cheaply collect large-scale data to support and evaluate policy decisions to contrast the spread of the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The overall study, the research protocol, and the survey instrument were approved by the Ethical Committee of the University Miguel Hernandez, named the Office for Responsible Research (OIR). OIR is the official body overseeing and regulating the experimental procedures and research activities to offer guarantees that they are conducted following the appropriate ethical and legal framework. The Ethical Committee was composed by the following members: Alberto Pastor (Univ Miguel Hernandez), Tomas de Domingo (Univ Miguel Hernandez), Javier Saez (Univ Miguel Hernandez), Eugenio Vilanova (univ Miguel Hernandez), Vicente Micol (Univ Miguel Hernandez), Antonio Guerrero (Univ Miguel Hernandez) and Ana Maria Madariaga (Univ of Alicante). Informed consent was obtained from all participants and appropriate institutional forms have been archived. The study was conducted following the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author M.D.N. ER -